MR
Muralidhara Ramachandra
About Muralidhara Ramachandra
Data last updated:
Muralidhara Ramachandra is a Ceo at Aurigene Oncology Limited (since 2019) and Director at Dr.Reddy's Institute Of Life Sciences (since 2024). The companies operate in Life Sciences, Pharma and Tourism And Accommodation. The 2 current companies with reported revenue have a combined latest revenue of ₹194 Cr; the largest is Aurigene Oncology Limited at ₹172 Cr (FY 2025). Earlier, Muralidhara Ramachandra was an Additional Director at Adhyaya Resorts And Spa Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 01 Jul 2019 | 2001 | ₹172 Cr (FY 2025) | Active | |
| Director | 23 Apr 2024 | 2003 | ₹22.14 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 28 Aug 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Muralidhara Ramachandra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muralidhara Ramachandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muralidhara Ramachandra
Muralidhara Ramachandra currently holds 2 directorships: Aurigene Oncology Limited (Ceo, since 01 Jul 2019, revenue ₹172 Cr (FY 2025)); Dr.Reddy's Institute Of Life Sciences (Director, since 23 Apr 2024, revenue ₹22.14 Cr (FY 2025)).
Muralidhara Ramachandra was first appointed on 01 Jul 2019 as Ceo at Aurigene Oncology Limited. The most recent appointment on record is 28 Aug 2024 at Adhyaya Resorts And Spa Private Limited.
The 2 current companies of Muralidhara Ramachandra that report revenue have a combined latest revenue of ₹194 Cr: Aurigene Oncology Limited ₹172 Cr (FY 2025); Dr.Reddy's Institute Of Life Sciences ₹22.14 Cr (FY 2025).
Muralidhara Ramachandra held 1 earlier board appointment: Adhyaya Resorts And Spa Private Limited (Additional Director, 28 Aug 2024 to 03 Nov 2025).
The current boards of Muralidhara Ramachandra's companies include Brijesh Kumar Karnani (Aurigene Oncology Limited), Bruce Leonard Andrews Carter (Aurigene Oncology Limited), Buggana Hariharnath (Aurigene Oncology Limited), Kumar Srinivasan (Aurigene Oncology Limited), Satish Reddy Kallam (Aurigene Oncology Limited), Shubhada Vivek Chiplunkar (Aurigene Oncology Limited), among others.